Table 1.
Compd | SKBR-3 cell growth inhibition (%) at 25μM | |
---|---|---|
1 | R1= CH3 R2= H | 13.9 ± 1.6 |
2 | R1= CH3 R2= CH3 | 13.7 ± 3.1 |
3 | R2= H | 16.6 ± 3.2 |
4 | R2= CH3 | 17.1 ± 3.4 |
5 | R2= H | 39.3 ± 2.9 |
6 | R2= CH3 | 57.5 ± 1.3 |
7 | R2= H | 29.1 ± 1.8 |
8 | R2= CH3 | 6.1 ± 2.0 |
9 | R2= H | 13.8 ± 2.3 |
10 | R2= CH3 | 10.6 ± 2.6 |
11 | R2= H | 61.6 ± 1.4 |
12 | R2= CH3 | 62.8 ± 0.8 |
13 | R2= H | 66.5 ± 0.3 |
14 | R2= CH3 | 35.2 ± 2.2 |
15 | R2= H | 31.3 ± 2.8 |
16 | R2= CH3 | 43.0 ± 3.7 |
SK-BR-3 cells were treated with indicated compounds at 25μM for 48 h and cell viability was measured by MTT assay as described in the experimental section, n = 6.